CIT 2015专访:钱菊英教授:中国冠心病的介入诊疗发展迅速

2015-04-01 MedSci MedSci原创

MedSci专访复旦大学附属中山医院心内科主任医师:钱菊英 MedSci:钱主任,您好!欢迎您来参加2015 CIT介入心脏病学大会。我们都知道您在冠心病的介入诊疗方面造诣颇深,您认为近些年中国冠心病的介入诊疗有什么突破性进展? 钱主任:近些年中国在冠心病的诊疗方面,无论是数量还是质量方面都取得了很大的进展。 首先,从数量方面看,根据霍勇教授统计的数据,201



MedSci专访复旦大学附属中山医院心内科主任医师:钱菊英

MedSci:钱主任,您好!欢迎您来参加2015 CIT介入心脏病学大会。我们都知道您在冠心病的介入诊疗方面造诣颇深,您认为近些年中国冠心病的介入诊疗有什么突破性进展?

钱主任:近些年中国在冠心病的诊疗方面,无论是数量还是质量方面都取得了很大的进展。

首先,从数量方面看,根据霍勇教授统计的数据,2014年中国冠心病的介入治疗有40余万例,这个数据在全球仅次于美国,排在第二位。但是中国冠心病患者基数较大,接受治疗的患者也多,中国的冠心病治疗还是需要继续发展的。

其次,从质量方面看,我国这些年正逐步推进介入治疗的规范化,质量在不断的提高中。

再次,从临床研究看,中国的冠心病介入治疗的研究涉及面广、发展快,如新支架的运用、围手术期药物使用等等。国内的介入治疗技术如针对复杂病变如完全闭塞病变、分叉病变等病变的介入治疗技术与全球保持同步,甚至占领先地位。同时,在推动介入的学术交流方面,除了CIT会议,还有东方心脏病学会议、介入心脏病学论坛等等。

MedSci:您率先在国内开展经冠状动脉内超声显像的体元模型三维重建,您有关冠脉内超声和多普勒血流测定等方面的研究处于国内领先的地位。您接下来在这个方面有什么新的进展?

钱主任:冠状动脉病变的评估,除了常规用的冠状动脉造影进行的解剖学、形态学方面的评估外,其实我们很多时候还要关注功能学方面的改变。这些年腔内影像和功能学评估的进展也是非常快的:从腔内影像方面看,包括血管内超声(intravascular ultrasound,IVUS)、光学干涉断层成像技术 (optical coherence tomography,OCT)等;再从功能评估方面看,多普勒属于超声领域的大范畴,多普勒检测还有一个功能就是测定冠状动脉血流,评估冠状动脉的微循环。当然评估某个病变本身是否有狭窄程度,还有基于冠脉内压力测定推算的冠状动脉血流储备分数FFR,目前不少研究探索FFR测定的新方法,包括无需给予扩血管药物的iFR,甚至无创的CT影像的方法,即CT-FFR。

这些进展为冠状动脉病变的形态学和功能学评估,以及指导治疗等方面带来了许多新的信息,可以作为是否该进行有创的冠状动脉造影以及是否需要进行血运重建等临床决策时的重要参考。心血管影像学,包括冠状动脉病变的无创性形态和功能评价方面的进展非常迅速。

MedSci:您在女性冠心病的诊断和治疗方面有什么看法?

钱主任:女性在冠心病患者中是一个特殊的群体,尽管总体来说,女性在绝经期前冠心病的平均发病年龄较男性晚近十年左右。但是在绝经期后,因心血管危险因素发生率的迅速增加,女性患者的冠心病发病率会明显增加。冠心病或者缺血性心脏病对女性死亡率的影响,尤其是老年人,与男性几乎是一样的。而冠心病的规范化治疗在女性患者中的应用要较男性更少,我们需要更多关注到冠心病对女性的危害。

对于女性来说,有些特殊的情况,比如说微血管功能不全在女性患者中的比例是超过男性的,也就是说女性更容易因为微血管功能不全而导致心肌缺血。

另外很重要的一点是,我们现在所采用的治疗的方法、措施来源于循证医学临床研究的结果。在临床研究中包括一部分的女性,但总体的比例比较低。女性跟男性的的治疗效果不一样,甚至预后也不一样,而我们普遍认为女性接受血运重建的治疗方法,可能会发生更多的并发症。所以基于女性这样的特殊性,我们需要给予女性冠心病患者更多的关注。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2086159, encodeId=abc92086159af, content=<a href='/topic/show?id=cee996501dd' target=_blank style='color:#2F92EE;'>#钱菊英#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96501, encryptionId=cee996501dd, topicName=钱菊英)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=346311, createdName=bnjfy, createdTime=Thu Oct 22 14:12:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703174, encodeId=fe771e031743b, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Sat Mar 12 20:12:00 CST 2016, time=2016-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814963, encodeId=607a181496387, content=<a href='/topic/show?id=2d56965024a' target=_blank style='color:#2F92EE;'>#钱菊英教授#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96502, encryptionId=2d56965024a, topicName=钱菊英教授)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5eee468, createdName=zxl729, createdTime=Mon Jun 15 23:12:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1738494, encodeId=fa031e3849427, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4763, encryptionId=a9dd4e63c4, topicName=CIT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eabf34462441, createdName=12498877m109暂无昵称, createdTime=Tue Sep 08 06:12:00 CST 2015, time=2015-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813065, encodeId=e41b181306587, content=<a href='/topic/show?id=4e1d9168e3b' target=_blank style='color:#2F92EE;'>#诊疗发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91687, encryptionId=4e1d9168e3b, topicName=诊疗发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=640c454, createdName=qblt, createdTime=Sun Nov 01 01:12:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19930, encodeId=272a199308d, content=具体问题具体分析吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Wed Apr 08 07:05:00 CST 2015, time=2015-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625472, encodeId=a33e16254e268, content=<a href='/topic/show?id=50062528930' target=_blank style='color:#2F92EE;'>#介入诊疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25289, encryptionId=50062528930, topicName=介入诊疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4bf20802872, createdName=luoxiaog, createdTime=Fri Apr 03 01:12:00 CST 2015, time=2015-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19274, encodeId=cc43192e450, content=介入手术放置支架的指征需要进一步细化明确,否则会加重过度医疗的乱象, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12781609448, createdName=wu2734033, createdTime=Fri Apr 03 00:44:00 CST 2015, time=2015-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19232, encodeId=bf051923214, content=中国人多,病人多,很需要先进的技术,高端人才啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ixiaochengdudu, createdTime=Wed Apr 01 12:24:00 CST 2015, time=2015-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19231, encodeId=69b71923176, content=女性这个特殊的群体,不仅仅是冠心病,在很多其他疾病治疗上都需要特别注意!在做研究中,更年期也是一个很大的研究点, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150602/IMG556D2C119C3EC8067.jpg, createdBy=e2ea89702, createdName=gongzuozhong, createdTime=Wed Apr 01 11:47:00 CST 2015, time=2015-04-01, status=1, ipAttribution=)]
    2015-10-22 bnjfy
  2. [GetPortalCommentsPageByObjectIdResponse(id=2086159, encodeId=abc92086159af, content=<a href='/topic/show?id=cee996501dd' target=_blank style='color:#2F92EE;'>#钱菊英#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96501, encryptionId=cee996501dd, topicName=钱菊英)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=346311, createdName=bnjfy, createdTime=Thu Oct 22 14:12:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703174, encodeId=fe771e031743b, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Sat Mar 12 20:12:00 CST 2016, time=2016-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814963, encodeId=607a181496387, content=<a href='/topic/show?id=2d56965024a' target=_blank style='color:#2F92EE;'>#钱菊英教授#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96502, encryptionId=2d56965024a, topicName=钱菊英教授)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5eee468, createdName=zxl729, createdTime=Mon Jun 15 23:12:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1738494, encodeId=fa031e3849427, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4763, encryptionId=a9dd4e63c4, topicName=CIT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eabf34462441, createdName=12498877m109暂无昵称, createdTime=Tue Sep 08 06:12:00 CST 2015, time=2015-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813065, encodeId=e41b181306587, content=<a href='/topic/show?id=4e1d9168e3b' target=_blank style='color:#2F92EE;'>#诊疗发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91687, encryptionId=4e1d9168e3b, topicName=诊疗发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=640c454, createdName=qblt, createdTime=Sun Nov 01 01:12:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19930, encodeId=272a199308d, content=具体问题具体分析吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Wed Apr 08 07:05:00 CST 2015, time=2015-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625472, encodeId=a33e16254e268, content=<a href='/topic/show?id=50062528930' target=_blank style='color:#2F92EE;'>#介入诊疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25289, encryptionId=50062528930, topicName=介入诊疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4bf20802872, createdName=luoxiaog, createdTime=Fri Apr 03 01:12:00 CST 2015, time=2015-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19274, encodeId=cc43192e450, content=介入手术放置支架的指征需要进一步细化明确,否则会加重过度医疗的乱象, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12781609448, createdName=wu2734033, createdTime=Fri Apr 03 00:44:00 CST 2015, time=2015-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19232, encodeId=bf051923214, content=中国人多,病人多,很需要先进的技术,高端人才啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ixiaochengdudu, createdTime=Wed Apr 01 12:24:00 CST 2015, time=2015-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19231, encodeId=69b71923176, content=女性这个特殊的群体,不仅仅是冠心病,在很多其他疾病治疗上都需要特别注意!在做研究中,更年期也是一个很大的研究点, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150602/IMG556D2C119C3EC8067.jpg, createdBy=e2ea89702, createdName=gongzuozhong, createdTime=Wed Apr 01 11:47:00 CST 2015, time=2015-04-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2086159, encodeId=abc92086159af, content=<a href='/topic/show?id=cee996501dd' target=_blank style='color:#2F92EE;'>#钱菊英#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96501, encryptionId=cee996501dd, topicName=钱菊英)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=346311, createdName=bnjfy, createdTime=Thu Oct 22 14:12:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703174, encodeId=fe771e031743b, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Sat Mar 12 20:12:00 CST 2016, time=2016-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814963, encodeId=607a181496387, content=<a href='/topic/show?id=2d56965024a' target=_blank style='color:#2F92EE;'>#钱菊英教授#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96502, encryptionId=2d56965024a, topicName=钱菊英教授)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5eee468, createdName=zxl729, createdTime=Mon Jun 15 23:12:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1738494, encodeId=fa031e3849427, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4763, encryptionId=a9dd4e63c4, topicName=CIT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eabf34462441, createdName=12498877m109暂无昵称, createdTime=Tue Sep 08 06:12:00 CST 2015, time=2015-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813065, encodeId=e41b181306587, content=<a href='/topic/show?id=4e1d9168e3b' target=_blank style='color:#2F92EE;'>#诊疗发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91687, encryptionId=4e1d9168e3b, topicName=诊疗发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=640c454, createdName=qblt, createdTime=Sun Nov 01 01:12:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19930, encodeId=272a199308d, content=具体问题具体分析吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Wed Apr 08 07:05:00 CST 2015, time=2015-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625472, encodeId=a33e16254e268, content=<a href='/topic/show?id=50062528930' target=_blank style='color:#2F92EE;'>#介入诊疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25289, encryptionId=50062528930, topicName=介入诊疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4bf20802872, createdName=luoxiaog, createdTime=Fri Apr 03 01:12:00 CST 2015, time=2015-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19274, encodeId=cc43192e450, content=介入手术放置支架的指征需要进一步细化明确,否则会加重过度医疗的乱象, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12781609448, createdName=wu2734033, createdTime=Fri Apr 03 00:44:00 CST 2015, time=2015-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19232, encodeId=bf051923214, content=中国人多,病人多,很需要先进的技术,高端人才啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ixiaochengdudu, createdTime=Wed Apr 01 12:24:00 CST 2015, time=2015-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19231, encodeId=69b71923176, content=女性这个特殊的群体,不仅仅是冠心病,在很多其他疾病治疗上都需要特别注意!在做研究中,更年期也是一个很大的研究点, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150602/IMG556D2C119C3EC8067.jpg, createdBy=e2ea89702, createdName=gongzuozhong, createdTime=Wed Apr 01 11:47:00 CST 2015, time=2015-04-01, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2086159, encodeId=abc92086159af, content=<a href='/topic/show?id=cee996501dd' target=_blank style='color:#2F92EE;'>#钱菊英#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96501, encryptionId=cee996501dd, topicName=钱菊英)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=346311, createdName=bnjfy, createdTime=Thu Oct 22 14:12:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703174, encodeId=fe771e031743b, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Sat Mar 12 20:12:00 CST 2016, time=2016-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814963, encodeId=607a181496387, content=<a href='/topic/show?id=2d56965024a' target=_blank style='color:#2F92EE;'>#钱菊英教授#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96502, encryptionId=2d56965024a, topicName=钱菊英教授)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5eee468, createdName=zxl729, createdTime=Mon Jun 15 23:12:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1738494, encodeId=fa031e3849427, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4763, encryptionId=a9dd4e63c4, topicName=CIT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eabf34462441, createdName=12498877m109暂无昵称, createdTime=Tue Sep 08 06:12:00 CST 2015, time=2015-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813065, encodeId=e41b181306587, content=<a href='/topic/show?id=4e1d9168e3b' target=_blank style='color:#2F92EE;'>#诊疗发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91687, encryptionId=4e1d9168e3b, topicName=诊疗发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=640c454, createdName=qblt, createdTime=Sun Nov 01 01:12:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19930, encodeId=272a199308d, content=具体问题具体分析吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Wed Apr 08 07:05:00 CST 2015, time=2015-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625472, encodeId=a33e16254e268, content=<a href='/topic/show?id=50062528930' target=_blank style='color:#2F92EE;'>#介入诊疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25289, encryptionId=50062528930, topicName=介入诊疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4bf20802872, createdName=luoxiaog, createdTime=Fri Apr 03 01:12:00 CST 2015, time=2015-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19274, encodeId=cc43192e450, content=介入手术放置支架的指征需要进一步细化明确,否则会加重过度医疗的乱象, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12781609448, createdName=wu2734033, createdTime=Fri Apr 03 00:44:00 CST 2015, time=2015-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19232, encodeId=bf051923214, content=中国人多,病人多,很需要先进的技术,高端人才啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ixiaochengdudu, createdTime=Wed Apr 01 12:24:00 CST 2015, time=2015-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19231, encodeId=69b71923176, content=女性这个特殊的群体,不仅仅是冠心病,在很多其他疾病治疗上都需要特别注意!在做研究中,更年期也是一个很大的研究点, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150602/IMG556D2C119C3EC8067.jpg, createdBy=e2ea89702, createdName=gongzuozhong, createdTime=Wed Apr 01 11:47:00 CST 2015, time=2015-04-01, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2086159, encodeId=abc92086159af, content=<a href='/topic/show?id=cee996501dd' target=_blank style='color:#2F92EE;'>#钱菊英#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96501, encryptionId=cee996501dd, topicName=钱菊英)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=346311, createdName=bnjfy, createdTime=Thu Oct 22 14:12:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703174, encodeId=fe771e031743b, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Sat Mar 12 20:12:00 CST 2016, time=2016-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814963, encodeId=607a181496387, content=<a href='/topic/show?id=2d56965024a' target=_blank style='color:#2F92EE;'>#钱菊英教授#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96502, encryptionId=2d56965024a, topicName=钱菊英教授)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5eee468, createdName=zxl729, createdTime=Mon Jun 15 23:12:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1738494, encodeId=fa031e3849427, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4763, encryptionId=a9dd4e63c4, topicName=CIT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eabf34462441, createdName=12498877m109暂无昵称, createdTime=Tue Sep 08 06:12:00 CST 2015, time=2015-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813065, encodeId=e41b181306587, content=<a href='/topic/show?id=4e1d9168e3b' target=_blank style='color:#2F92EE;'>#诊疗发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91687, encryptionId=4e1d9168e3b, topicName=诊疗发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=640c454, createdName=qblt, createdTime=Sun Nov 01 01:12:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19930, encodeId=272a199308d, content=具体问题具体分析吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Wed Apr 08 07:05:00 CST 2015, time=2015-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625472, encodeId=a33e16254e268, content=<a href='/topic/show?id=50062528930' target=_blank style='color:#2F92EE;'>#介入诊疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25289, encryptionId=50062528930, topicName=介入诊疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4bf20802872, createdName=luoxiaog, createdTime=Fri Apr 03 01:12:00 CST 2015, time=2015-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19274, encodeId=cc43192e450, content=介入手术放置支架的指征需要进一步细化明确,否则会加重过度医疗的乱象, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12781609448, createdName=wu2734033, createdTime=Fri Apr 03 00:44:00 CST 2015, time=2015-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19232, encodeId=bf051923214, content=中国人多,病人多,很需要先进的技术,高端人才啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ixiaochengdudu, createdTime=Wed Apr 01 12:24:00 CST 2015, time=2015-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19231, encodeId=69b71923176, content=女性这个特殊的群体,不仅仅是冠心病,在很多其他疾病治疗上都需要特别注意!在做研究中,更年期也是一个很大的研究点, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150602/IMG556D2C119C3EC8067.jpg, createdBy=e2ea89702, createdName=gongzuozhong, createdTime=Wed Apr 01 11:47:00 CST 2015, time=2015-04-01, status=1, ipAttribution=)]
    2015-11-01 qblt
  6. [GetPortalCommentsPageByObjectIdResponse(id=2086159, encodeId=abc92086159af, content=<a href='/topic/show?id=cee996501dd' target=_blank style='color:#2F92EE;'>#钱菊英#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96501, encryptionId=cee996501dd, topicName=钱菊英)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=346311, createdName=bnjfy, createdTime=Thu Oct 22 14:12:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703174, encodeId=fe771e031743b, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Sat Mar 12 20:12:00 CST 2016, time=2016-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814963, encodeId=607a181496387, content=<a href='/topic/show?id=2d56965024a' target=_blank style='color:#2F92EE;'>#钱菊英教授#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96502, encryptionId=2d56965024a, topicName=钱菊英教授)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5eee468, createdName=zxl729, createdTime=Mon Jun 15 23:12:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1738494, encodeId=fa031e3849427, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4763, encryptionId=a9dd4e63c4, topicName=CIT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eabf34462441, createdName=12498877m109暂无昵称, createdTime=Tue Sep 08 06:12:00 CST 2015, time=2015-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813065, encodeId=e41b181306587, content=<a href='/topic/show?id=4e1d9168e3b' target=_blank style='color:#2F92EE;'>#诊疗发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91687, encryptionId=4e1d9168e3b, topicName=诊疗发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=640c454, createdName=qblt, createdTime=Sun Nov 01 01:12:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19930, encodeId=272a199308d, content=具体问题具体分析吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Wed Apr 08 07:05:00 CST 2015, time=2015-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625472, encodeId=a33e16254e268, content=<a href='/topic/show?id=50062528930' target=_blank style='color:#2F92EE;'>#介入诊疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25289, encryptionId=50062528930, topicName=介入诊疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4bf20802872, createdName=luoxiaog, createdTime=Fri Apr 03 01:12:00 CST 2015, time=2015-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19274, encodeId=cc43192e450, content=介入手术放置支架的指征需要进一步细化明确,否则会加重过度医疗的乱象, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12781609448, createdName=wu2734033, createdTime=Fri Apr 03 00:44:00 CST 2015, time=2015-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19232, encodeId=bf051923214, content=中国人多,病人多,很需要先进的技术,高端人才啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ixiaochengdudu, createdTime=Wed Apr 01 12:24:00 CST 2015, time=2015-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19231, encodeId=69b71923176, content=女性这个特殊的群体,不仅仅是冠心病,在很多其他疾病治疗上都需要特别注意!在做研究中,更年期也是一个很大的研究点, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150602/IMG556D2C119C3EC8067.jpg, createdBy=e2ea89702, createdName=gongzuozhong, createdTime=Wed Apr 01 11:47:00 CST 2015, time=2015-04-01, status=1, ipAttribution=)]
    2015-04-08 hbwang006

    具体问题具体分析吧

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2086159, encodeId=abc92086159af, content=<a href='/topic/show?id=cee996501dd' target=_blank style='color:#2F92EE;'>#钱菊英#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96501, encryptionId=cee996501dd, topicName=钱菊英)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=346311, createdName=bnjfy, createdTime=Thu Oct 22 14:12:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703174, encodeId=fe771e031743b, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Sat Mar 12 20:12:00 CST 2016, time=2016-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814963, encodeId=607a181496387, content=<a href='/topic/show?id=2d56965024a' target=_blank style='color:#2F92EE;'>#钱菊英教授#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96502, encryptionId=2d56965024a, topicName=钱菊英教授)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5eee468, createdName=zxl729, createdTime=Mon Jun 15 23:12:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1738494, encodeId=fa031e3849427, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4763, encryptionId=a9dd4e63c4, topicName=CIT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eabf34462441, createdName=12498877m109暂无昵称, createdTime=Tue Sep 08 06:12:00 CST 2015, time=2015-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813065, encodeId=e41b181306587, content=<a href='/topic/show?id=4e1d9168e3b' target=_blank style='color:#2F92EE;'>#诊疗发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91687, encryptionId=4e1d9168e3b, topicName=诊疗发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=640c454, createdName=qblt, createdTime=Sun Nov 01 01:12:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19930, encodeId=272a199308d, content=具体问题具体分析吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Wed Apr 08 07:05:00 CST 2015, time=2015-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625472, encodeId=a33e16254e268, content=<a href='/topic/show?id=50062528930' target=_blank style='color:#2F92EE;'>#介入诊疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25289, encryptionId=50062528930, topicName=介入诊疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4bf20802872, createdName=luoxiaog, createdTime=Fri Apr 03 01:12:00 CST 2015, time=2015-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19274, encodeId=cc43192e450, content=介入手术放置支架的指征需要进一步细化明确,否则会加重过度医疗的乱象, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12781609448, createdName=wu2734033, createdTime=Fri Apr 03 00:44:00 CST 2015, time=2015-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19232, encodeId=bf051923214, content=中国人多,病人多,很需要先进的技术,高端人才啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ixiaochengdudu, createdTime=Wed Apr 01 12:24:00 CST 2015, time=2015-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19231, encodeId=69b71923176, content=女性这个特殊的群体,不仅仅是冠心病,在很多其他疾病治疗上都需要特别注意!在做研究中,更年期也是一个很大的研究点, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150602/IMG556D2C119C3EC8067.jpg, createdBy=e2ea89702, createdName=gongzuozhong, createdTime=Wed Apr 01 11:47:00 CST 2015, time=2015-04-01, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=2086159, encodeId=abc92086159af, content=<a href='/topic/show?id=cee996501dd' target=_blank style='color:#2F92EE;'>#钱菊英#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96501, encryptionId=cee996501dd, topicName=钱菊英)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=346311, createdName=bnjfy, createdTime=Thu Oct 22 14:12:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703174, encodeId=fe771e031743b, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Sat Mar 12 20:12:00 CST 2016, time=2016-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814963, encodeId=607a181496387, content=<a href='/topic/show?id=2d56965024a' target=_blank style='color:#2F92EE;'>#钱菊英教授#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96502, encryptionId=2d56965024a, topicName=钱菊英教授)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5eee468, createdName=zxl729, createdTime=Mon Jun 15 23:12:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1738494, encodeId=fa031e3849427, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4763, encryptionId=a9dd4e63c4, topicName=CIT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eabf34462441, createdName=12498877m109暂无昵称, createdTime=Tue Sep 08 06:12:00 CST 2015, time=2015-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813065, encodeId=e41b181306587, content=<a href='/topic/show?id=4e1d9168e3b' target=_blank style='color:#2F92EE;'>#诊疗发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91687, encryptionId=4e1d9168e3b, topicName=诊疗发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=640c454, createdName=qblt, createdTime=Sun Nov 01 01:12:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19930, encodeId=272a199308d, content=具体问题具体分析吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Wed Apr 08 07:05:00 CST 2015, time=2015-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625472, encodeId=a33e16254e268, content=<a href='/topic/show?id=50062528930' target=_blank style='color:#2F92EE;'>#介入诊疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25289, encryptionId=50062528930, topicName=介入诊疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4bf20802872, createdName=luoxiaog, createdTime=Fri Apr 03 01:12:00 CST 2015, time=2015-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19274, encodeId=cc43192e450, content=介入手术放置支架的指征需要进一步细化明确,否则会加重过度医疗的乱象, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12781609448, createdName=wu2734033, createdTime=Fri Apr 03 00:44:00 CST 2015, time=2015-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19232, encodeId=bf051923214, content=中国人多,病人多,很需要先进的技术,高端人才啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ixiaochengdudu, createdTime=Wed Apr 01 12:24:00 CST 2015, time=2015-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19231, encodeId=69b71923176, content=女性这个特殊的群体,不仅仅是冠心病,在很多其他疾病治疗上都需要特别注意!在做研究中,更年期也是一个很大的研究点, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150602/IMG556D2C119C3EC8067.jpg, createdBy=e2ea89702, createdName=gongzuozhong, createdTime=Wed Apr 01 11:47:00 CST 2015, time=2015-04-01, status=1, ipAttribution=)]
    2015-04-03 wu2734033

    介入手术放置支架的指征需要进一步细化明确,否则会加重过度医疗的乱象

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2086159, encodeId=abc92086159af, content=<a href='/topic/show?id=cee996501dd' target=_blank style='color:#2F92EE;'>#钱菊英#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96501, encryptionId=cee996501dd, topicName=钱菊英)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=346311, createdName=bnjfy, createdTime=Thu Oct 22 14:12:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703174, encodeId=fe771e031743b, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Sat Mar 12 20:12:00 CST 2016, time=2016-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814963, encodeId=607a181496387, content=<a href='/topic/show?id=2d56965024a' target=_blank style='color:#2F92EE;'>#钱菊英教授#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96502, encryptionId=2d56965024a, topicName=钱菊英教授)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5eee468, createdName=zxl729, createdTime=Mon Jun 15 23:12:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1738494, encodeId=fa031e3849427, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4763, encryptionId=a9dd4e63c4, topicName=CIT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eabf34462441, createdName=12498877m109暂无昵称, createdTime=Tue Sep 08 06:12:00 CST 2015, time=2015-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813065, encodeId=e41b181306587, content=<a href='/topic/show?id=4e1d9168e3b' target=_blank style='color:#2F92EE;'>#诊疗发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91687, encryptionId=4e1d9168e3b, topicName=诊疗发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=640c454, createdName=qblt, createdTime=Sun Nov 01 01:12:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19930, encodeId=272a199308d, content=具体问题具体分析吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Wed Apr 08 07:05:00 CST 2015, time=2015-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625472, encodeId=a33e16254e268, content=<a href='/topic/show?id=50062528930' target=_blank style='color:#2F92EE;'>#介入诊疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25289, encryptionId=50062528930, topicName=介入诊疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4bf20802872, createdName=luoxiaog, createdTime=Fri Apr 03 01:12:00 CST 2015, time=2015-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19274, encodeId=cc43192e450, content=介入手术放置支架的指征需要进一步细化明确,否则会加重过度医疗的乱象, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12781609448, createdName=wu2734033, createdTime=Fri Apr 03 00:44:00 CST 2015, time=2015-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19232, encodeId=bf051923214, content=中国人多,病人多,很需要先进的技术,高端人才啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ixiaochengdudu, createdTime=Wed Apr 01 12:24:00 CST 2015, time=2015-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19231, encodeId=69b71923176, content=女性这个特殊的群体,不仅仅是冠心病,在很多其他疾病治疗上都需要特别注意!在做研究中,更年期也是一个很大的研究点, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150602/IMG556D2C119C3EC8067.jpg, createdBy=e2ea89702, createdName=gongzuozhong, createdTime=Wed Apr 01 11:47:00 CST 2015, time=2015-04-01, status=1, ipAttribution=)]
    2015-04-01 ixiaochengdudu

    中国人多,病人多,很需要先进的技术,高端人才啊

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2086159, encodeId=abc92086159af, content=<a href='/topic/show?id=cee996501dd' target=_blank style='color:#2F92EE;'>#钱菊英#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96501, encryptionId=cee996501dd, topicName=钱菊英)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=346311, createdName=bnjfy, createdTime=Thu Oct 22 14:12:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703174, encodeId=fe771e031743b, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Sat Mar 12 20:12:00 CST 2016, time=2016-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814963, encodeId=607a181496387, content=<a href='/topic/show?id=2d56965024a' target=_blank style='color:#2F92EE;'>#钱菊英教授#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96502, encryptionId=2d56965024a, topicName=钱菊英教授)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5eee468, createdName=zxl729, createdTime=Mon Jun 15 23:12:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1738494, encodeId=fa031e3849427, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4763, encryptionId=a9dd4e63c4, topicName=CIT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eabf34462441, createdName=12498877m109暂无昵称, createdTime=Tue Sep 08 06:12:00 CST 2015, time=2015-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813065, encodeId=e41b181306587, content=<a href='/topic/show?id=4e1d9168e3b' target=_blank style='color:#2F92EE;'>#诊疗发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91687, encryptionId=4e1d9168e3b, topicName=诊疗发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=640c454, createdName=qblt, createdTime=Sun Nov 01 01:12:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19930, encodeId=272a199308d, content=具体问题具体分析吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Wed Apr 08 07:05:00 CST 2015, time=2015-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625472, encodeId=a33e16254e268, content=<a href='/topic/show?id=50062528930' target=_blank style='color:#2F92EE;'>#介入诊疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25289, encryptionId=50062528930, topicName=介入诊疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4bf20802872, createdName=luoxiaog, createdTime=Fri Apr 03 01:12:00 CST 2015, time=2015-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19274, encodeId=cc43192e450, content=介入手术放置支架的指征需要进一步细化明确,否则会加重过度医疗的乱象, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12781609448, createdName=wu2734033, createdTime=Fri Apr 03 00:44:00 CST 2015, time=2015-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19232, encodeId=bf051923214, content=中国人多,病人多,很需要先进的技术,高端人才啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ixiaochengdudu, createdTime=Wed Apr 01 12:24:00 CST 2015, time=2015-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19231, encodeId=69b71923176, content=女性这个特殊的群体,不仅仅是冠心病,在很多其他疾病治疗上都需要特别注意!在做研究中,更年期也是一个很大的研究点, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150602/IMG556D2C119C3EC8067.jpg, createdBy=e2ea89702, createdName=gongzuozhong, createdTime=Wed Apr 01 11:47:00 CST 2015, time=2015-04-01, status=1, ipAttribution=)]
    2015-04-01 gongzuozhong

    女性这个特殊的群体,不仅仅是冠心病,在很多其他疾病治疗上都需要特别注意!在做研究中,更年期也是一个很大的研究点

    0

相关资讯

Circulation:青壮年高脂血症会增加随后冠心病风险

  最新AHA/ACC指南推荐≥60岁的成人服用他汀治疗,而对于青壮年而言,只有少部分符合他汀治疗目标。青壮年长期高血脂水平,随后的冠心病发生风险并没有得到足够的研究。杜克大学医学中心Navar-Boggan等人从Framingham子代研究中选取33-55岁的青壮年(年龄小于55岁),探讨高血脂与未来冠心病风险之间的关系,其研究成果发表在1月份circulation期刊上。&nb

JACC:冠心病事件患者出院后未进行充分高强度他汀治疗

AHA/ACC指南中建议,冠心病患者应进行高强度他汀治疗降血脂,从而减少动脉粥样硬化性心血管疾病的风险,尤其是急性冠脉综合症的患者出院后的患者。然而,只有少部分研究有报道冠心病事件发生后患者应用高强度他汀治疗。出院后高强度他汀治疗的研究并不够充分。因此,纽约西奈山医学院Rosenson RS等人研究了冠心病事件发生后使用高强度他汀治疗患者的比例,分析了入院前后他汀治疗强度的相关性,其研究成果发

Lancet:通过遗传变异型预估冠心病风险

目前的学界已经认识到,遗传变异与冠心病的发病风险密切相关。在本研究中,来自美国布莱根妇女医院与哈佛医学院的Mega医生领导的研究组进行了一项分析工作,验证遗传变异型中是否有组分能够协助判断冠心病的发病与复发的风险,并找出接受抑制素疗法临床疗效更好的人群。 该研究选取了1项基于社区的队列研究(the Malmo Diet and Cancer Study),4项随机对照试验包括了初级预防(JU

Twitter能够预测冠心病发生?

Twitter(推特)是一个社交网络及微博客服务的网站,是全球互联网上访问量最大的十个网站之一。它允许用户将自己的最新动态和想法以短信形式发送给手机和个性化网站群,通过快速、及时、直接的传递信息达到对社会各方面产生深远的影响。然而,来自美国宾夕法尼亚大学的研究人员通过最新的研究发现,推特除了作为社会媒体平台以外,还能够有效地指示社区心理状态,并且,它还能够预测冠心病的发病率。 既往的研究发现

Eur Heart J :疲劳:社会心理因素对于冠心病风险的预测性

对于冠心病的预防人群研究起始于1940年,而介入治疗也是从之后的1970年开始的。1961年,冠心病的风险因子首次在Framingham Study中发表,其中包括高血压,高血脂等等。之后又有新的风险因子被添加。1970年,心理社会因素也被添加入冠心病的风险因子中。开创性的心脏病研究,源于52个国家的15152例心梗病例分析中提到,传统风险因子对于90%的患者具有预测性,而心理社会因素也对32

NEJM:顽固性心绞痛患者的福音来了

顽固性心绞痛患者的福音来了背景许多有冠心病的患者并不适合使用血管再生药物进行治疗顽固性心绞痛,尽管这一措施符合治疗标准。我们使用了一个利用气囊膨胀原理、不锈钢、沙漏形、减少冠状窦的新设备,将该设备放置在一个冠状窦最集中狭窄的部位,增加冠状窦压力,血液也因此分配到缺血心肌,采用这个原理治疗顽固性心绞痛。方式实验参与人员为104位由加拿大心血管协会(CCS)评定心功能为三级或者四级和心肌缺血的患者(心